A smart gel formulation that provides fast and intense pain relief as early as one week for osteoarthritis patients. It reduces co-medication and improves mobility and quality of life for the patients. 7 out 10 osteoarthritis patients report treatment response within 1 week after injection. The powerful effect on pain is still maintained 6 months after injection.
It contains 2% of Hyaluronic Acid and 4% of Sorbitol. Hyaluronic acid (HA) has a biofermentation origin and is highly purified with no risk of allergy caused by animal proteins. Sorbitol is a natural antioxidant used in the pharmaceutical industry that strongly protects HA from degradation. Synolis VA recommended injection regimen for the knee and hip in a single session: Hyaluronic Acid 80 mg + Sorbitol 160 mg.
Choose SYNOLIS VA for your Osteoarthritis Patients
BioEsque Medical provides consultancy service with the appointed distributors in South East Asia to market Synolis VA